Pedersen, M.
, D'Amore, F. A., Pedersen, L. M., Jensen, B. A., Jensen, P., Pedersen, B. B., Møller, M. B., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S., Klausen, T. W. & Brown, P. D. N. (2012).
A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, United States.
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Noerregaard, P., Moeller, MB.
, Steiniche, T. & D'Amore, F. A. (2014).
High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma.
Histopathology,
65(4), 490–500.
https://doi.org/10.1111/his.12407
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Nørgaard, P., Møller, M. B., Raffeld, M., Pittaluga, S.
, Steiniche, T., Bergmann, A., Vater, I., Siebert, R., Chan, W.-C.
& D'Amore, F. A. (2014).
Identification of a subset of peripheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome.
Blood,
124(21).
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B., Nørgaard, P., Johansen, P., Ralfkiaer, E., Brown, P. D. N., Hansen, P. B., Jensen, B. A., Madsen, J., Schöllkopf, C.
& d'Amore, F. (2014).
Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry.
Hematological Oncology (Online),
33(4), 120-128.
https://doi.org/10.1002/hon.2153
Pedersen, M. B., Riber-Hansen, R.
, Nielsen, P. S., Bendix, K.
, Hamilton-Dutoit, S. J., D'Amore, F. & Steiniche, T. (2014).
Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomas.
Applied Immunohistochemistry & Molecular Morphology,
22(8), 577-84.
https://doi.org/10.1097/PAI.0b013e3182a7d16d
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B., Raffeld, M., Pittaluga, S.
, Steiniche, T., Bergmann, A., Vater, I., Siebert, R., Chan, W. C.
& D'Amore, F. A. (2014).
Identification of a subset of perpheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome. Identification of a subset of perpheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome. .
Blood,
124(21), Article 124.
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Ketterling, R. P., Bedroske, P. P., Luoma, I. M., Sattler, C. A., Boddicker, R. L., Bennani, N. N., Nørgaard, P., Møller, M. B.
, Steiniche, T., d'Amore, F. & Feldman, A. L. (2017).
DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.
Blood,
130(4), 554-557.
https://doi.org/10.1182/blood-2016-12-755496
Pedersen, M. B., Hamilton Dutoit, S. J., Bendix, K., Ketterling, RP., Bedroske, PP., Luoma, IM., CA, S., Bennani-Baiti, N., Nørgaard, P., Møller, MB.
, Steiniche, T. & d'Amore, F. A. (2017).
First independent validation fo DUSP22 and TP63 rearrangements as outcome predictors in ALK-negative anaplastic large cell lymphoma: a Danish cohort study. Blood.
Pedersen, M. A.
, Gormsen, L. C., Kamper, P., Wassberg, C., Andersen, M. D., d'Amore, A. L., Barrington, S. F., Johnson, P.
, Hamilton-Dutoit, S., Amini, R. M., Enblad, G., Molin, D.
& d'Amore, F. (2019).
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy.
British Journal of Haematology,
186(3), 431-439.
https://doi.org/10.1111/bjh.15933
Olsson, L., Behnke, O., Pleibel, N.
, d'Amore, F. A., Werdelin, O., Fry, KE. & Kaplan, HS. (1984).
Establishment and characterization of a giant cell line from a patient with Hodgkin's disease.
Journal of the National Cancer Institute,
73, 809-30.
O'Connor, O. A., Bhagat, G., Ganapathi, K.
, Pedersen, M. B., D'Amore, F., Radeski, D. & Bates, S. E. (2014).
Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.
Clinical Cancer Research,
20(20), 5240-54. Article e006363.
https://doi.org/10.1158/1078-0432.CCR-14-2020
O'Connor, O. A., Özcan, M., Jacobsen, E. D., Roncero, J. M., Trotman, J., Demeter, J., Masszi, T., Pereira, J., Ramchandren, R., Beaven, A., Caballero, D., Horwitz, S. M., Lennard, A., Turgut, M., Hamerschlak, N.
, d'Amore, F. A., Foss, F., Kim, W.-S., Leonard, J. P. ... Lumiere Study Investigators (2019).
Randomized ohase III study of alisertib or investigator's choice (selected single agent) in patients with relapsed or refractory peripheral T-Cell lymphoma.
Journal of Clinical Oncology,
37(8), 613-623.
https://doi.org/10.1200/JCO.18.00899
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, NA.
, Steiniche, T., Bang, K.
, Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (ALZ) is effective against severe paraneoplastic pemphigus (PNP).
British Journal of Dermatology.
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A.
, Steiniche, T., Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (alz) is effective against severe chronic lymphocytic leukemia-associated paraneoplastic pemphigus (pnp).
British Journal of Dermatology,
169(2).
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A.
, Steiniche, T., Bang, K.
, Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia.
British Journal of Dermatology,
169(2), 469-472.
Neldeborg, S., Soerensen, J. F., Møller, C. T., Bill, M., Gao, Z.
, Bak, R. O., Holm, K.
, Sorensen, B., Nyegaard, M.
, Luo, Y., Hokland, P., Stougaard, M., Ludvigsen, M. & Holm, C. K. (2023).
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.
Leukemia,
37(9), 1792-1801.
https://doi.org/10.1038/s41375-023-01950-9
Muzzulini, C.
, d'Amore, F. A., Sobrero, A., Massa, G., Bogliolo, G., Ghio, R. & Pannacciulli, I. (1981).
Evaluation of doxorubicin toxicity on normal haemopoietic stem cells.
Tumori,
67, 293-300.
Muzzulini, C.
, d'Amore, F. A., Sobrero, A., Massa, G., Bogliolo, G. & Pannacciulli, I. (1984).
Leucovorin protection on pluripotent hemopoietic stem cells in mice treated with high-dose methotrexate. Tumori,
70, 223-26.
Mortensen, J. B., Monrad, I., Enemark, M. B., Ludvigsen, M., Kamper, P., Bjerre, M. & d'Amore, F. (2021).
Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
European Journal of Haematology,
107(1), 81-91.
https://doi.org/10.1111/ejh.13621
Morschhauser, F., Radford, J., Van Hoof, A., Vitolo, U., Soubeyran, P., Tilly, H., Huijgens, P. C., Kolstad, A.
, d'Amore, F., Gonzalez Diaz, M., Petrini, M., Sebban, C., Zinzani, P. L., van Oers, M. H. J., van Putten, W., Bischof-Delaloye, A., Rohatiner, A., Salles, G., Kuhlmann, J. & Hagenbeek, A. (2008).
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Journal of Clinical Oncology,
26(32), 5156-64.
https://doi.org/10.1200/JCO.2008.17.2015
Monrad, I., Madsen, C.
, Lauridsen, K. L., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S., D’Amore, F. & Ludvigsen, M. (2020).
Glycolytic biomarkers predict transformation in patients with follicular lymphoma.
PLOS ONE,
15(5), Article e0233449.
https://doi.org/10.1371/journal.pone.0233449
Møller, M., Rath, M. F.
, Ludvigsen, M., Honoré, B. & Vorum, H. (2017).
Diurnal expression of proteins in the retina of the blind cone-rod homeobox (Crx(-/-) ) mouse and the 129/Sv mouse: a proteomic study.
Acta Ophthalmologica,
7(95), 717-726.
https://doi.org/10.1111/aos.13429
Meier, M., Andersen, K. J., Knudsen, A. R., Ludvigsen, M., Honoré, B. & Mortensen, F. V. (2016).
Extended hepatectomy induces pronounced changes in protein expression levels..
Meier, M., Knudsen, A. R., Andersen, K. J., Ludvigsen, M., Eriksen, P. L., Honoré, B. & Mortensen, F. V. (2019).
Upregulation of ureagenesis may be pivotal for survival of post-hepatectomy liver failure in rats. Poster session presented at 13th Congress of the European – African Hepato-Pancreato-Biliary Association, Amsterdam, Netherlands.
Meier, M., Knudsen, A. R., Andersen, K. J., Ludvigsen, M., Lykke Eriksen, P., Pedersen, A. K. N., Honoré, B. & Mortensen, F. V. (2019).
Perturbations of urea cycle enzymes during post-hepatectomy rat liver failure.
American Journal of Physiology: Gastrointestinal and Liver Physiology,
317(4), G429-G440.
https://doi.org/10.1152/ajpgi.00293.2018
Massa, G., Bogliolo, G.
, d'Amore, F. A., Muzzulini, C., Ghio, R. & Pannacciulli, I. (1982).
Haemopoietic precursor cells in mice treated with 4-demethoxydaunorubicin and doxorubicin.
Journal of the National Cancer Institute,
68, 971-976.
Mannisto, S., Vähämurto, P., Pollari, M., Clausen, M. R., Jyrkkiö, S., Kellokumpu-Lehtinen, P. L., Kovanen, P., Karjalainen-Lindsberg, M. L.
, d'Amore, F. & Leppä, S. (2019).
Intravenous but not intrathecal central nervous system–directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma.
European Journal of Cancer,
115, 27-36.
https://doi.org/10.1016/j.ejca.2019.04.004
Mandrup-Poulsen, T., Mølvig, J., Andersen, V., Bendtzen, K., Binder, C., Brøns, M.
, d'Amore, F. A., Dieperink, H., Erik, B., Frandsen, NE., Haase, H., Hey, H., Juul, J., Karstoft, E., Kemp, E., Laursen, HB., Mogensen, EF., Nerup, J., Pedersen, KE. ... Sagild, U. (1990).
Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study.
Ugeskrift for Laeger,
152(27), 1963-9.
Maksten, E. F., Vase, M. Ø., Kampmann, J.
, d'Amore, F., Møller, M. B., Strandhave, C., Bendix, K., Bistrup, C., Thiesson, H. C.
, Søndergaard, E., Hamilton-Dutoit, S. & Jespersen, B. (2016).
Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.
Transplant International,
29(4), 483-493.
https://doi.org/10.1111/tri.12744
Madsen, C.
, Pedersen, M. B., Segel, E., Bendix, K., Jensen, B. A., Jensen, P., Moelller, M. B., Johansen, P., Munksgaard, L., Brown, P.
& D'Amore, F. A. (2013).
upfront autologous stem-cell transplantation in transformed indolent non-hodgkins lymphoma: An outcome analysis.
Hematological Oncology,
31.
Madsen, C.
, Pedersen, M. B., Vase, M. Ø., Bendix, K., Møller, M. B., Johansen, P., Jensen, BA., Munksgaard, L., Brown, P. D. N., Segel, E.
& D'Amore, F. A. (2015).
Outcome determinants for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology,
26(2), 393-9.
https://doi.org/10.1093/annonc/mdu537
Madsen, C.
, Pedersen, M. B., Vase, M. Ø., Segel, E., Bendix, K., Jensen, B. A., Jensen, P., Møller, M. B., Johansen, P., Munksgaard, L., Brown, P. D. N.
& D'Amore, F. A. (2014).
Clinical outcome determinats for sequentially transformed indolent lymphomas treated with or without autologous stem cell transplantation.
Blood,
124(21).
Madsen, C.
, Pedersen, M. B., Vase, M. Ø., Segel, E. K., Bendix, K., Jensen, BA., Møller, M. B., Johansen, P., Munksgaard, L., Brown, P. D. N.
& D'Amore, F. A. (2015).
outcome determinats for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology,
26(2), 393-399.
Madsen, C., Clausen, M. R., Plesner, T. L., Pasanen, A., Kuismanen, T., Bentzen, H. H.
, Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Rønnov-Jessen, D.
, Jensen, K. R., Pettinger, A. M.
, Ludvigsen, M., Leppä, S.
& d'Amore, F. A. (2018).
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study.
Blood Advances,
2(13), 1562-1571.
https://doi.org/10.1182/bloodadvances.2018017673
Madsen, C.
, Lauridsen, K. L., Plesner, T. L., Monrad, I.
, Honoré, B., Hamilton-Dutoit, S., d’Amore, F. & Ludvigsen, M. (2019).
High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma.
Blood Cancer Journal,
9(4), Article 35.
https://doi.org/10.1038/s41408-019-0197-5
Madsen, C., Plesner, T. L., Bentzen, H. H. N.
, Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Josefsson, P., Plesner, T., Bennedsen, T. L.
, Ludvigsen, M. & d'Amore, F. A. (2020).
Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort.
Leukemia and Lymphoma,
61(11), 2584-2594 .
https://doi.org/10.1080/10428194.2020.1779254
Lugtenburg, PJ., Brown, P. D. N., Van der Holt, B.
, D'Amore, F. A., Koene, HR., Berenschot, HW., Fijnheer, R., Loosveld, O., Bohmer, LH., Pruijt, H., Verhoef, G., Hoogendoorn, M., de Kan, R., Van Imhoff, GW., van Hooije, C., Lam, KH., de Keizer, B., de Jong, D., Hoekstra, OS. & Zijlstra, JM. (2016).
Randomized phase III study on the effect of early intensification of Rituximab in combination with 2-weekly CHOP chemotherapy flollowed by Rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group Study. Abstract from ASCO Annual Meeting, United States.
Lugtenburg, P. J., De Nully Brown, P., Van der Holt, B.
, D'Amore, F. A., Koene, H. R., De Jongh, E., Fijnheer, R., Van Esser, J. W., Bohmer, L. H., Pruijt, J. F., Verhoef, G. E., Hoogendoorn, M., Bilgin, M. Y., Nijland, M., Van der Burg-De Graauw, N. C., Oosterveld, M., Jie, K. S. G., Larsen, T. S., Van der Poel, M. W. ... Zijlstra-Baalbergen, J. M. (2020).
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84).
Journal of Clinical Oncology,
38(29), 3377-3387.
https://doi.org/10.1200/JCO.19.03418
Ludvigsen, M., Ostergaard, M., Vorum, H., Jacobsen, C.
& Honoré, B. (2009).
Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity.
B M C Biochemistry,
10(1), 34.
https://doi.org/10.1186/1471-2091-10-34
Ludvigsen, M., Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Moeller, M. B., Noergaard, P.
, D'Amore, F. A. & Honoré, B. (2013).
Proteomic analysis identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Hematological Oncology,
31, 174-175.
Ludvigsen, M., Madsen, C.
, Kamper, P., Hamilton-Dutoit, S. J., Bendix, K.
, D'Amore, F. A. & Honoré, B. (2013).
Proteomic analysis identifies differential expression patterns in follicular lymphoma patients with or without subsequent histological transformation.
Hematological Oncology,
31, 203.
Ludvigsen, M., Kamper, P., Sørensen, B. S., Møller, M. B., Bendix, K.
, Hamilton-Dutoit, S. J., Alsner, J., D'Amore, F. A. & Honoré, B. (2015).
Differential protein expression of peroxiredoxin-1 in classical Hodgkin Lymphoma: a possible correlation to clinical behaviour.
Hematological Oncology,
33, 253-255.
https://doi.org/10.1002/hon.2157